Tris Pharma
US Highway 130
Monmouth Junction
NJ
08852
United States
Tel: (732) 940-2800
Website: https://www.trispharma.com/
About Tris Pharma
Founded in 2000, Tris Pharma, Inc. (www.trispharma.com) is the 3rd largest specialty pharmaceutical company in the United States. With our intense focus on the application of physical chemistry in biological systems, coupled with the requirements of manufacturing and market demands, we have grown our employee base over 250% in the past three years. Specifically, we are engaged in research, development, and manufacturing of both OTC and Rx branded products and specialty generic products. Our mission is to understand the science driving the delivery of drugs into the human body;develop and bring to market products that add value to our customers and patients and provide a benefit to our company, employees and society at large.
89 articles about Tris Pharma
-
First Product in Tris Pharma, Inc.'s Collaboration With Vernalis PLC Achieves Proof-of-Concept, Triggering Milestone Payment to Tris
3/12/2013
-
Tris Pharma, Inc. Appoints New Vice President of Business Development
11/15/2012
-
Tris Pharma, Inc. Expands U.S. Ops, Plans to Create 75-100 New Jobs
10/22/2012
-
Perrigo Company and Tris Pharma, Inc. Launch Store Brand Version of Delsym®
8/27/2012
-
Tris Pharma, Inc. Expands Manufacturing Capacity and Strengthens Supply Chain to Support New and Pending Approvals
7/11/2012
-
Tris Pharma, Inc. Goes on Hiring Binge; Aims to Increase Workforce by 40 Pct. in Next 6 Months
6/15/2012
-
Perrigo Company Announces Tris Pharma, Inc. Final Approval of Tris Pharma, Inc.'s Dextromethorphan Polistirex Extended-Release Oral Suspension
5/30/2012
-
Tris Pharma, Inc. Announces Management Additions, Promotion
5/10/2012
-
Tris Pharma, Inc. Announces Appointment of Dr. Mahdi Fawzi as Top R&D Executive
1/25/2012
-
Tris Pharma, Inc. Announces US Patent Grant Covering Platform Technology
1/6/2012
-
Tris Pharma, Inc. Expands Leadership Team, Adds Senior Managers in Quality and Finance
8/18/2011
-
Tris Pharma, Inc. Appoints Vice President of Human Resources
6/29/2011
-
Tris Pharma, Inc. Announces Availability of the MyKidz(R) Iron Product Line - the Best Tasting Iron Supplements
3/29/2011
-
Tris Pharma, Inc. Announces NDA Acceptance of Extended Release Carbinoxamine Oral Suspension for the Treatment of Allergies in Kids Two Years and Older
3/9/2011
-
Tris Pharma, Inc. Announces Approval of First-Ever Generic of Tussionex(R) Extended-Release Suspension
10/8/2010
-
NextWave Pharmaceuticals and Tris Pharma, Inc. Enter into CNS-focused Development and Commercialization Agreement
8/12/2010
-
Tris Pharma, Inc. Announces Approval of First-Time Generic of Methylphenidate Hydrochloride Oral Solution With Six Months Exclusivity
7/28/2010
-
Breckenridge Pharmaceutical, Inc. to Market Methylphenidate Oral Solution Through Agreement With Tris Pharma, Inc.
7/28/2010
-
Perrigo Company Acquires Exclusive Sales and Distribution Rights to Generic Version of Delsym(R) from Tris Pharma, Inc.
5/5/2010
-
Tris Pharma, Inc. Announces Key Executive Hiring of Vice President of Corporate Development
4/7/2010